Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/16/2025

Empirical Antibiotic Treatment for Septic Shock

Initial Antibiotic Selection

  • The Society of Critical Care Medicine recommends that intravenous antimicrobials must be initiated as soon as possible and within one hour of recognizing septic shock to reduce mortality 1, 2
  • Empiric broad-spectrum therapy should cover all likely pathogens (bacterial, potentially fungal or viral) 1, 2
  • For septic shock, use combination therapy with at least two antibiotics from different antimicrobial classes 1, 2
  • For respiratory failure with septic shock: combine an extended-spectrum β-lactam with either an aminoglycoside or fluoroquinolone when Pseudomonas aeruginosa is suspected 1, 2
  • For septic shock from Streptococcus pneumoniae bacteremia: combine a β-lactam with a macrolide 1, 2

Duration and De-escalation

  • Empiric combination therapy should not be administered for more than 3-5 days 1, 2
  • De-escalation to the most appropriate single therapy should be performed once susceptibility profile is known 1, 2
  • Daily assessment for de-escalation of antimicrobial therapy is recommended 1, 2
  • Standard duration for serious infections associated with sepsis and septic shock is 7-10 days 1, 2

Special Considerations for Extended Treatment

  • Longer courses may be appropriate in patients with slow clinical response to initial therapy 1, 2
  • Longer courses may be appropriate in patients with undrainable foci of infection 1, 2
  • Longer courses may be appropriate in patients with bacteremia with Staphylococcus aureus 1, 2
  • Longer courses may be appropriate in patients with fungal and viral infections 1, 2
  • Longer courses may be appropriate in patients with immunologic deficiencies, including neutropenia 1, 2

Dosing Optimization

  • Optimize antibiotic dosing strategies based on pharmacokinetic/pharmacodynamic principles 1, 2

Common Pitfalls to Avoid

  • Failure to de-escalate: Continuing broad-spectrum antibiotics beyond 3-5 days when culture results are available increases resistance risk 1, 2
  • Inappropriate duration: Treating longer than necessary (typically >10 days) without specific indications 1, 2
  • Antimicrobial agents should not be used in patients with severe inflammatory states determined to be of noninfectious cause 1, 2

Source-Specific Considerations

  • For suspected fungal infections: add appropriate antifungal therapy 1, 2
  • For viral infections: initiate antiviral therapy as early as possible 1, 2